Subodh Saggi is a Nephrology physician affiliated with New York City Health and Hospitals Corporation. OpenAlex indexes 95 publications with 1,896 citations (h-index 19); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
450 Clarkson Ave
Msc 52
Brooklyn, NY 112032012
Telephone
718-270-1585Registry record last updated 12 Jun 2015.
Clinical trials
- Observational Study of Kibow Biotics in Chronic Kidney Failure Patients on Dialysis
Sponsor: Kibow Pharma
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Vifor Pharma, Inc.Program year20251 payment
- Calliditas Therapeutics US Inc.Program year20231 payment
- Mozarc Medical US LLCProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
58.9%Statin16.3%Rosuvastatin Calcium58%Atorvastatin Calcium42%Part D<11 patientsAngiotensin receptor blocker (ARB)11.4%Losartan Potassium100%Part D≥12 patients+ 4 more classes in this area
Metabolism & gastrointestinal
35.6%SGLT2 inhibitor18.3%Farxiga60%Jardiance41%Part D<11 patientsVitamin D3 Analog11.9%Calcitriol50%Rayaldee50%Part D<11 patients+ 1 more class in this area
Hormonal (systemic)
5.4%Calcium-sensing Receptor Agonist5.4%Cinacalcet Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Analysis of Pediatric vs. Adult Patients with ESRD Using Peritoneal Dialysis (PD) and Kidney Transplantation from Real-World IPRO Data
Journal of the American Society of Nephrology
2025 - Thrombotic Microangiopathy That Comes with the Job: Chemist
Journal of the American Society of Nephrology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Bijan Safai, MD
New York City Health and Hospitals Corporation
Joan Reibman, MD
New York City Health and Hospitals Corporation
Nora Bergasa, MD
New York City Health and Hospitals Corporation
Andrew Wiznia, MD
New York City Health and Hospitals Corporation
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”